CD14 and Parkinson disease: The findings from the two-sample Mendelian randomization indicated that CD14+ CD16+ monocytes, HLA DR+ NK cells in CD3− lymphocytes, and CD28 on activated & secreting Tregs were positively correlated with an increased risk of PD.